Management of chronic myeloid leukemia in 2025.
Saved in:
| Title: | Management of chronic myeloid leukemia in 2025. |
|---|---|
| Authors: | Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Breccia M; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hehlmann R; Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Malhotra H; Department of Medical Oncology, Sri Ram Cancer Center, Mahatma Gandhi Medical College Hospital, Jaipur, India., Nicolini FE; Hematology Department, Centre Léon Bérard, Lyon, France.; Centre de Recherche en Cancerologie de Lyon, Institut National de la Santé et de la Recherche Médicale, Lyon, France., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Stenke L; Division of Haematology, Department of Medicine, Karolinska Hospital and Institutet, Stockholm, Sweden., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
| Source: | Cancer [Cancer] 2025 Jul 15; Vol. 131 (14), pp. e35953. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0142 |
|---|---|
| DOI: | 10.1002/cncr.35953 |
